Pfizer, Moderna bivalent COVID booster nods could land this week: report

After weeks of hazy timelines, Moderna and Pfizer-BioNTech’s omicron-adapted booster shots appear to be right around the corner.

The FDA could authorize the variant-targeted mRNA vaccines as early as Wednesday, Politico first reported, citing three people close to the decision.